Cited by 242Diabetes Management and ResearchDiabetes Management and EducationDiabetes Treatment and Management

Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes

Nimri, Revital, Battelino, Tadej, Laffel, Lori M., Slover, Robert H., Schatz, Desmond, Weinzimer, Stuart A., Dovc, Klemen, Danne, Thomas +62 more·2020·Nature Medicine

Abstract

Despite the increasing adoption of insulin pumps and continuous glucose monitoring devices, most people with type 1 diabetes do not achieve their glycemic goals 1. This could be related to a lack of expertise or inadequate time for clinicians to analyze complex sensor-augmented pump data. We tested whether frequent insulin dose adjustments guided by an automated artificial intelligence-based decision support system (AI-DSS) is as effective and safe as those guided by physicians in controlling glucose levels. ADVICE4U was a six-month, multicenter, multinational, parallel, randomized controlled, non-inferiority trial in 108 participants with type 1 diabetes, aged 10-21 years and using insulin pump therapy (ClinicalTrials.gov no. NCT03003806). Participants were randomized 1:1 to receive remote insulin dose adjustment every three weeks guided by either an AI-DSS, (AI-DSS arm, n = 54) or by physicians (physician arm, n = 54). The results for the primary efficacy measure-the percentage of time spent within the target glucose range (70-180 mg dl-1 (3.9-10.0 mmol l-1))-in the AI-DSS arm were statistically non-inferior to those in the physician arm (50.2 ± 11.1% versus 51.6 ± 11.3%, respectively, P < 1 × 10-7). The percentage of readings below 54 mg dl-1 (<3.0 mmol l-1) within the AI-DSS arm was statistically non-inferior to that in the physician arm (1.3 ± 1.4% versus 1.0 ± 0.9%, respectively, P < 0.0001). Three severe adverse events related to diabetes (two severe hypoglycemia, one diabetic ketoacidosis) were reported in the physician arm and none in the AI-DSS arm. In conclusion, use of an automated decision support tool for optimizing insulin pump settings was non-inferior to intensive insulin titration provided by physicians from specialized academic diabetes centers.

Integrity signals

Registry

Crossref · 10.1038/s41591-020-1045-7

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 27 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Nimri, R., Battelino, T., Laffel, L. M., Slover, R. H., Schatz, D., Weinzimer, S. A., Dovc, K., Danne, T., Phillip, M., NextDREAM Consortium, Phillip, M., Nimri, R., Shalitin, S., Bello, R., Nevo-Shenker, M., Fisch-Shvalb, N., Shiovitch-Mantzuri, G., Choresh, O., Drutz, I., Nava, Y., Hemo, A., Hermon, O., Nave, R., Battelino, T., Dovc, K., Bratina, N., Smigoe-Schweiger, D., Mali, B., Gianini, A., Sever, U., Berkopec, B. M., Laffel, L. M., Katz, M., Isganaitis, E., Mehta, S., Quinn, H., Naik, N., Guo, Z., Volkening, L., Slover, R. H., Forlenza, G., Wadwa, R. P., Alonso, G. T., Messer, L., Towers, L., Thivener, K., Berget, C., Lange, S., Jost, E., Rossick-Solis, M., Schatz, D., Haller, M., Hiers, P., Jacobsen, L., Smith, M., O’Neill, A., Hosford, J., Perry, A., Weinzimer, S. A., Cengiz, E., Sherr, J., Gibbons, K., Carria, L., Zgorski, M., Danne, T., Biester, T., Kordonouri, O., von dem Berge, T., Biester, S., & Remus, K.
Affiliations
  • Schneider Children's Medical Center (IL)
  • University of Ljubljana (SI)
  • Joslin Diabetes Center (US)
  • University of Colorado Anschutz (US)
  • University of Florida (US)
  • Yale University (US)
  • Kinderkrankenhaus auf der Bult (DE)
Venue
Nature Medicine
Published
2020-09
Volume
26
Issue
9
Pages
1380-1384
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W3084252132
Cited by
242
References
27
Citations by year
2026: 18 · 2025: 42 · 2024: 58 · 2023: 52 · 2022: 41 · 2021: 28 · 2020: 3
FWCI
23.38
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
The Leona M. and Harry B. Helmsley Charitable Trust
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 1 diabetes, artificial intelligence, clinical decision support systems, insulin pump therapy, continuous glucose monitoring, adolescents, glycemic control, non-inferiority, hypoglycemia, diabetic ketoacidosis
MeSH terms
Adolescent, Artificial Intelligence, Blood Glucose, Child, Diabetes Mellitus, Type 1, Humans, Insulin, Insulin Infusion Systems, Blood Glucose Self-Monitoring, Treatment Outcome, Decision Support Systems, Clinical, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review